LONDON — The U.K. government has drawn up proposals to increase the amount the National Health Service pays pharmaceutical firms for drugs, in a bid to steer U.S. President Donald Trump away from his threatened tariffs on the sector. Officials briefed the Trump administration on fresh proposals to adjust how the NHS prices medicines earlier this week, two industry figures told POLITICO. The core element of the plan includes raising the National Institute for Health and Care Excellence (NICE)

Tag-uri: Donald Trump